 |
Although No-Cost Prep Is Safe For Now, Ruling Still Leaves Free Preventive Care At Risk
AAHIVM | June 27, 2024
|
|
Gilead's long-acting HIV drug superior to daily pill Truvada in study
Reuters | June 20, 2024
|
|
Long-Acting Oral Combo for HIV Maintains Viral Suppression at Week 24
IDSE | June 15, 2024
|
|
Two-Drug Dolutegravir-Based Antiretroviral Therapy Supported for HIV Management
Infectious Disease Advisor | June 12, 2024
|
|
NIH launches two clinical trials on long-acting HIV PrEP
PharmaNews | June 7, 2024
|
|
Dr. Mermin Discusses New Doxy PEP Guidelines for STI Prevention
HIV.gov | June 6, 2024
|
|
CDC Publishes Doxy PEP Clinical Guidelines for Bacterial STI Prevention
HIV.gov | June 4, 2024
|
|
Pharma firm urged to share new 'game-changer' HIV drug
Medical Xpress | May 30, 2024
|
|
HIV Preexposure Prophylaxis (PrEP)
National HIV Curriculum | May 6, 2024
|
|
Feasibility of Implementing a Low-Barrier Long-Acting Injectable Antiretroviral Program for HIV Treatment and Prevention for People...
NIH | May 1, 2024
|
|
Caution advised when prescribing long-acting injectable cabotegravir and rilpivirine to avoid drug resistance
Aidsmap | April 30, 2024
|
|
FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
GILEAD | April 26, 2024
|
|
Long-Acting Drugs May Revolutionize H.I.V. Prevention and Treatment
The New York Times | April 17, 2024
|
|
More evidence that PrEP works as well for women
Aidsmap | April 17, 2024
|
|
Considerations for Implementing Cabotegravir (Apretude) as PrEP for HIV Infection
AAFP | April 2024
|
|
FDA Approves Dovato for Teens Living With HIV
Drugs.com | April 10, 2024
|
|
FDA approves dolutegravir/lamivudine to treat HIV infection in adolescents
Contemporary Pediatrics | April 8, 2024
|
|
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons...
Oxford Academic - Oxford University Press | April 6, 2024
|
|
Understanding HIV drug resistance, implications for treatment strategies
PharmaNewsIntelligence | March 25, 2024
|
|
Many Americans Are Unaware of HIV Prevention Medication
KFF | March 20, 2024
|
| |
|
|
|
New drug candidates show promise to reverse HIV immune evasion
News Medical | March 19, 2024
|
|
U.S. FDA Approves EDURANT® PED (rilpivirine) for Certain Pediatric Patients Living with HIV-1
Johnson & Johnson | March 19, 2024
|
|
HIV Medications 101
AETC | March 19, 2024
|
|
People who struggle with daily HIV regimen should be offered long-acting injections
Healio | CROI 2024 | March 9, 2024
|
|
Investigational two-drug regimen safe, effective for patients with HIV
Healio | CROI2024 | March 6, 2024
|
|
PrEP use up, HIV incidence down, data show
Healio | CROI2024 | March 5, 2024
|
|
Dolutegravir-Based ART Efficacious for HIV Management Through 192 Weeks
Infectious Disease Advisor | March 13, 2024
|
|
Semaglutide Reduces Liver Fat in People Living With HIV
POZ | March 13, 2024
|
|
Ultra-Long-Acting Cabotegravir Could Be Given Every Four Months
POZ | March 11, 2024
|
|
New treatment options for critically important WHO fungal priority pathogens
Clin Microbiol Infect. 2024 Mar 8:S1198-743X(24)00118-6. doi: 10.1016/j.cmi.2024.03.006
|
|
Examining a Newer Therapy for Heavily Treated HIV Patients
Contagion Live | March 7, 2024
|
|
Gilead’s Innovative HIV Treatment Research Pipeline Aims to Address Unmet Needs and Advance Public Health
Gilead | March 5, 2024
|
|
New report documents increase in HIV drug resistance to dolutegravir
WHO | March 5, 2024
|
|
New HIV Drugs on the Horizon (webinar)
IAS-USA | February 19, 2024
|
|
Antiretroviral Medications and Initial Therapy
National HIV Curriculum | February 11, 2024
|
|
2024 Session: Florida may allow pharmacists to prescribe HIV prevention drugs
Tallahassee Democrat | February 9, 2024
|
|
Do Higher PrEP Costs Affect Risk for Subsequent HIV Infection?
NEJM | January 29, 2024
|
|
How Does Smoking Affect People with HIV?
HIV.gov | January 26, 2024
|
|
Enhancing quality of life and medication adherence for people living with HIV: the impact of an information system
NIH | January 23, 2024
|
|
New Antibiotic Effective Against Drug-Resistant Bacteria, Study Indicates
CNN | January 3, 2024
|
| |
|
|
